Bioskills educators & facilities: teaching the next generation of surgeons their craft

Over 2,000 physicians and allied health professionals participate in bioskills training programs at T3 Labs every year. Among them is Dr. Keith Delman, director of the Carlos and Davis Center for Surgical Anatomy and Technique at the Emory University School of Medicine. Board certified by the American Board of Surgery as well, Dr. Delman shared…

ASAIO 2016: Our Discoveries and Takeaways

We would like to thank Jeremy Kimmel and ALung Technologies for recommending such a wonderful and productive conference: ASAIO 2016. The ASAIO (the American Society for Artificial Internal Organs) event provided us with new insight into new pre-clinical models for heart and respiratory devices. Some of our insights and takeaways from this conference included: During…

Update: State of Medtech Innovation in the Southeast

T3 Labs Training Program Director Kelley Bennett joined SEMDA Executive Director Jason Rupp and GCMI Executive Director Tiffany Wilson on Health Connect South Radio last week. Give a listen to the current state of medtech innovation in the southeast and how T3 Labs supports our vibrant medtech ecosystem. Via our colleagues Jay Schaffer and CW…

Talking device innovation for gastro, GI and more at DDW 2016

“DDW is the largest annual gathering of surgeons, hepatologists, and gastroenterologists from around the world. The breadth of content covered — from liver to pancreas to colorectal — ensures that every attendee, no matter their specialty, type of practice, or level of experience will benefit from the program. For trainees as well as practicing surgeons,…

Cardiothoracic connections at AATS 2016

Over 1,300 of the world’s foremost cardiothoracic surgeons comprise The American Association of Thoracic Surgery. It is the definition of an industry leading organization in thoracic surgery. “Other than visiting a surgeon in his or her own operating room, there is no opportunity like [AATS] in education in thoracic surgery,” according to Charles D. Fraser,…

JACC-CI study & ACC Distinguished Award winner evidence T3 leads the way in preclinical cardiovascular research

T3 Labs is committed to excellence in translational research including preclinical cardiovascular research. After all, our program leaders are scientists, too. This is most recently evident in the journal article “Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent…